M Makris Selected Research

M Makris Research Topics

Disease

23	Hemorrhage 05/2018 - 12/2000
22	Hemophilia A (Haemophilia) 05/2018 - 12/2000
6	Thrombosis (Thrombus) 01/2015 - 03/2000
6	von Willebrand Diseases (von Willebrand's Disease) 05/2013 - 09/2002
4	Hemophilia B (Haemophilia B) 01/2018 - 05/2012
4	Inflammation (Inflammations) 03/2016 - 01/2008
4	Venous Thrombosis (Deep-Vein Thrombosis) 06/2011 - 03/2000
4	Protein S Deficiency (Deficiency, Protein S) 03/2005 - 03/2000
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2011 - 04/2009
3	Protein C Deficiency 10/2008 - 12/2000
3	Thrombophilia 09/2004 - 03/2002
2	Factor XIII Deficiency 12/2017 - 08/2017
2	Neoplasms (Cancer) 03/2017 - 09/2012
2	Hypersensitivity (Allergy) 06/2016 - 03/2010
2	Asthma (Bronchial Asthma) 09/2010 - 07/2005
2	Myocardial Infarction 12/2000 - 06/2000
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Headache (Headaches) 01/2018
1	Disease Susceptibility (Diathesis) 12/2017
1	Immune System Diseases (Immune Disorders) 03/2017
1	Arthritis (Polyarthritis) 03/2016
1	Pain (Aches) 03/2016
1	Joint Diseases (Joint Disease) 03/2016
1	Infections 03/2016
1	Angiodysplasia 05/2015
1	Bites and Stings (Sting) 04/2015
1	Anaphylaxis (Anaphylactic Shock) 01/2014
1	Hepatitis A (Hepatitis, Infectious) 05/2013
1	Colorectal Neoplasms (Colorectal Cancer) 09/2012
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2012
1	Hepatocellular Carcinoma (Hepatoma) 09/2012
1	Prostatic Neoplasms (Prostate Cancer) 09/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2012
1	Inherited Blood Coagulation Disorders 05/2012
1	Pulmonary Embolism 06/2011
1	Virus Diseases (Viral Diseases) 05/2011
1	Onychomycosis (Tinea Unguium) 01/2011
1	Fibrosis (Cirrhosis) 09/2010
1	Rhinitis 09/2010
1	Lentigo (Lentiginosis) 07/2010
1	Nail Diseases (Nail Disease) 05/2010

Drug/Important Bio-Agent (IBA)

8	Factor VIII (Coagulation Factor VIII)IBA 03/2017 - 09/2002
7	Blood Coagulation Factors (Coagulation Factor)IBA 06/2016 - 03/2010
6	recombinant FVIIa (rFVIIa)FDA Link 07/2014 - 12/2000
5	von Willebrand FactorIBA 05/2015 - 04/2004
5	AnticoagulantsIBA 01/2015 - 04/2004
5	Protein CIBA 10/2008 - 12/2000
4	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2018 - 09/2013
4	Thrombin FDA Link 09/2010 - 09/2008
4	Protein SIBA 09/2004 - 03/2000
3	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2018 - 07/2012
3	Fibrinogen (Factor I)FDA Link 12/2017 - 09/2008
3	Prothrombin (Factor II)IBA 07/2014 - 12/2000
3	AntithrombinsIBA 06/2011 - 09/2004
3	Antiviral Agents (Antivirals)IBA 05/2011 - 09/2006
3	optivateIBA 05/2011 - 03/2011
3	factor V LeidenIBA 06/2009 - 03/2002
2	IB1001IBA 01/2018 - 11/2012
2	CoagulantsIBA 01/2017 - 09/2008
2	IsoantibodiesIBA 06/2016 - 09/2013
2	Warfarin (Coumadin)FDA LinkGeneric 03/2016 - 01/2015
2	Histamine (Histamine Dihydrochloride)FDA Link 04/2015 - 01/2014
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 04/2011 - 03/2002
2	AllergensIBA 09/2010 - 10/2008
2	Immunoglobulin E (IgE)IBA 09/2010 - 03/2010
2	Proteins (Proteins, Gene)FDA Link 01/2010 - 01/2004
2	InterferonsIBA 08/2007 - 09/2006
2	prothrombin complex concentrates (PPSB)IBA 01/2004 - 12/2000
1	A-factor (Streptomyces)IBA 05/2018
1	emicizumabIBA 05/2018
1	Factor XIII (Coagulation Factor XIII)IBA 01/2017
1	recombinant factor VIII SQIBA 09/2016
1	human F8 protein FDA Link 09/2016
1	Analgesics (Analgesic Drugs)IBA 03/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2016
1	Capsules (Microcapsules)IBA 05/2015
1	Vitamin K FDA Link 01/2015
1	Neutralizing AntibodiesIBA 03/2014
1	Ranitidine (Zantac)FDA LinkGeneric 01/2014
1	Therapeutic UsesIBA 07/2012
1	IceIBA 07/2012
1	Indicators and Reagents (Reagents)IBA 04/2011
1	Ustekinumab (CNTO 1275)FDA Link 01/2011
1	ElementsIBA 01/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	Epinephrine (Adrenaline)FDA LinkGeneric 10/2010
1	CatecholaminesIBA 10/2010
1	snake venom protein C activatorIBA 09/2010
1	Biomarkers (Surrogate Marker)IBA 09/2010
1	Phenylalanine (L-Phenylalanine)FDA Link 07/2010
1	Adalimumab (Humira)FDA Link 05/2010
1	VenomsIBA 03/2010

Therapy/Procedure

9	Therapeutics 01/2015 - 07/2005
3	Aftercare (After-Treatment) 09/2016 - 09/2002
1	Drug Therapy (Chemotherapy) 09/2012
1	Radiotherapy 09/2012
1	Arthroplasty 05/2011
1	Donor Selection 05/2011
1	Vascular Access Devices (Arterial Line) 05/2011